RxDoctor Payments Data

Melissa Kirkwood, MD

Vascular Surgery · Dallas, TXNPI 1043444565

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $7,695 of the $11,763 with a category attached, or 65.4%. W. L. Gore & Associates, Inc. accounts for 87.1% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2022 at $4,283 and has fallen 92.0% since, to $343 in 2025.

$11,763in general payments, 2019–2025

Across 44 payments — averaging $267.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • W. L. Gore & Associates, Inc.$10K
  • Medtronic$755
  • Boston Scientific$286
  • Shockwave Medical, Inc$208
  • Lemaitre Vascular, Inc.$120
  • Surmodics, Inc.$88
  • plus $56 from 2 others
$33,817in research payments, 2019–2025

Across 6 payments — averaging $5636.17 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • W. L. Gore & Associates, Inc.$34K

What the payments were for

  • Consulting fees$7,69565%
  • Speaking & faculty fees$3003%
  • Grants$4003%
  • Travel & lodging$590%
  • Food & beverage$3,30928%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,763 in reported general payments places this provider in the 65th percentile of 347 vascular surgery providers in Texas.

See all vascular surgery providers in Texas

Medicare billing

Part B allowed, 2024
$235,021
Medicare patients
793
Services billed
1,443

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClopidogrelClopidogrel Bisulfate40$315
Prednisone14$20

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Dallas

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →